Editorial
World J Hepatol
16(1):1-11.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.1
Abstract (707)
|
Core Tip (796)
|
Full Article (HTML) (2617)
|
Figures (1-1) (526)
|
Full Article (PDF)-1204K (220)
|
Full Article with Cover (PDF)-11949K (264)
|
Full Article (XML)-236K (142)
|
Audio-1342K (11)
|
Peer-Review Report-230K (158)
|
Answering Reviewers-97K (143)
|
Received: 10/26/2023
|
Revised: 12/04/2023
|
Accepted: 12/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (8334)
|
Similar Articles (78)
|
Timeline of Article Publication (1)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):12-16.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.12
Abstract (741)
|
Core Tip (789)
|
Full Article (HTML) (1887)
|
Tables (1-1) (599)
|
Full Article (PDF)-358K (181)
|
Full Article with Cover (PDF)-11106K (244)
|
Full Article (XML)-54K (127)
|
Audio-1072K (15)
|
Peer-Review Report-236K (118)
|
Answering Reviewers-62K (116)
|
Received: 11/09/2023
|
Revised: 12/05/2023
|
Accepted: 12/19/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (6803)
|
Similar Articles (21)
|
Timeline of Article Publication (1)
|
Authors Evaluation (8)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions
World J Hepatol
16(1):17-32.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.17
Abstract (851)
|
Core Tip (682)
|
Full Article (HTML) (7173)
|
Figures (1-2) (561)
|
Tables (1-5) (554)
|
Full Article (PDF)-1655K (306)
|
Full Article with Cover (PDF)-12399K (265)
|
Full Article (XML)-226K (150)
|
Audio-1259K (14)
|
Peer-Review Report-216K (135)
|
Answering Reviewers-145K (131)
|
Received: 09/16/2023
|
Revised: 12/02/2023
|
Accepted: 01/03/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (21)
|
Total Visits (12596)
|
Similar Articles (69)
|
Timeline of Article Publication (1)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):33-40.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.33
Abstract (822)
|
Core Tip (735)
|
Full Article (HTML) (3969)
|
Figures (1-1) (555)
|
Full Article (PDF)-601K (309)
|
Full Article with Cover (PDF)-11346K (191)
|
Full Article (XML)-89K (143)
|
Audio-384K (14)
|
Peer-Review Report-180K (122)
|
Answering Reviewers-74K (138)
|
Received: 10/10/2023
|
Revised: 11/06/2023
|
Accepted: 01/05/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (27)
|
Total Visits (9001)
|
Similar Articles (346)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study
World J Hepatol
16(1):41-53.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.41
Abstract (788)
|
Core Tip (701)
|
Article Highlights (716)
|
Full Article (HTML) (2699)
|
Figures (1-4) (498)
|
Tables (1-3) (501)
|
Full Article (PDF)-1672K (194)
|
Full Article with Cover (PDF)-12418K (184)
|
Full Article (XML)-173K (123)
|
Audio-467K (8)
|
Peer-Review Report-182K (117)
|
Answering Reviewers-71K (153)
|
Received: 11/21/2023
|
Revised: 12/18/2023
|
Accepted: 01/09/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (9178)
|
Similar Articles (2138)
|
Timeline of Article Publication (2)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes
World J Hepatol
16(1):54-64.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.54
Abstract (754)
|
Core Tip (760)
|
Article Highlights (870)
|
Full Article (HTML) (2298)
|
Figures (1-3) (576)
|
Tables (1-2) (539)
|
Full Article (PDF)-1874K (203)
|
Full Article with Cover (PDF)-12619K (217)
|
Full Article (XML)-114K (146)
|
Audio-386K (20)
|
Peer-Review Report-233K (139)
|
Answering Reviewers-161K (133)
|
Received: 10/02/2023
|
Revised: 10/22/2023
|
Accepted: 12/18/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (10803)
|
Similar Articles (14)
|
Timeline of Article Publication (4)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Subcellular distribution of prohibitin 1 in rat liver during liver regeneration and its cellular implication
World J Hepatol
16(1):65-74.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.65
Abstract (661)
|
Core Tip (637)
|
Article Highlights (700)
|
Full Article (HTML) (1668)
|
Figures (1-4) (480)
|
Full Article (PDF)-5746K (183)
|
Full Article with Cover (PDF)-16492K (182)
|
Full Article (XML)-96K (135)
|
Audio-3997K (13)
|
Peer-Review Report-192K (124)
|
Answering Reviewers-146K (130)
|
Received: 09/30/2023
|
Revised: 11/03/2023
|
Accepted: 11/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (7434)
|
Similar Articles (43)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease
World J Hepatol
16(1):75-90.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.75
Abstract (742)
|
Core Tip (719)
|
Article Highlights (782)
|
Full Article (HTML) (2854)
|
Figures (1-4) (476)
|
Tables (1-5) (501)
|
Full Article (PDF)-6006K (221)
|
Full Article with Cover (PDF)-16750K (215)
|
Full Article (XML)-200K (128)
|
Audio-376K (9)
|
Peer-Review Report-182K (134)
|
Answering Reviewers-60K (138)
|
Supplementary Material-355K (129)
|
Received: 11/03/2023
|
Revised: 12/11/2023
|
Accepted: 01/02/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (11582)
|
Similar Articles (1982)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis
World J Hepatol
16(1):91-102.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.91
Abstract (665)
|
Core Tip (733)
|
Article Highlights (718)
|
Full Article (HTML) (2015)
|
Figures (1-4) (509)
|
Tables (1-4) (494)
|
Full Article (PDF)-5941K (190)
|
Full Article with Cover (PDF)-16687K (199)
|
Full Article (XML)-115K (135)
|
Audio-187K (10)
|
Peer-Review Report-215K (131)
|
Answering Reviewers-37K (146)
|
Received: 10/20/2023
|
Revised: 11/21/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (9052)
|
Similar Articles (2663)
|
Timeline of Article Publication (3)
|
Authors Evaluation (5)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hepatol
16(1):103-108.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.103
Abstract (707)
|
Core Tip (726)
|
Full Article (HTML) (1795)
|
Figures (1-1) (554)
|
Full Article (PDF)-5068K (207)
|
Full Article with Cover (PDF)-15813K (184)
|
Full Article (XML)-63K (126)
|
Audio-811K (8)
|
Peer-Review Report-266K (137)
|
Answering Reviewers-225K (133)
|
Received: 08/25/2023
|
Revised: 10/24/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (7807)
|
Similar Articles (4525)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients
World J Hepatol
16(1):109-111.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.109
Abstract (708)
|
Core Tip (757)
|
Full Article (HTML) (1773)
|
Full Article (PDF)-325K (156)
|
Full Article with Cover (PDF)-11079K (189)
|
Full Article (XML)-24K (134)
|
Audio-243K (4)
|
Peer-Review Report-215K (103)
|
Answering Reviewers-19K (112)
|
Received: 10/30/2023
|
Revised: 12/04/2023
|
Accepted: 01/12/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5613)
|
Similar Articles (405)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
